Clinical Trial Update: To Evaluate the Treatment Effect of an Anti-Infective Agent for Different Kinds of Infections (0826-052) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating an anti-infective agent for infections including pneumonia and urinary tract infection; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Urinary Tract Infection

Drugs mentioned

• Anti-infective agent (0826-052)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Infection, Pneumonia | Phase 3 | Status: COMPLETED